Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Lamictal as add-on therapy for bipolar I disorder in children and adolescents
2015-004872-31Phase 3
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Lamotrigine add-on with Placebo add-on (2 arms). Primary endpoint: Time to occurrence of a bipolar event (TOBE).
02
Drugs
lamotrigine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2015-004872-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004872-31.